Results 171 to 180 of about 12,579 (209)

Idiopathic Inflammatory Myopathies

Rheumatic Disease Clinics of North America, 2019
Major advances have been made in the field of idiopathic inflammatory myopathies (IIM), or myositis, that are likely to facilitate development of new therapeutic strategies that have not yet been applied in this group of diseases. These advances include new classification criteria to better identify the patients with IIM, detection of several new ...
Jiří, Vencovský, Helene, Alexanderson, Ingrid E, Lundberg   +2 more
openaire   +2 more sources

Combining MRI and muscle biopsy improves diagnostic accuracy in subacute‐onset idiopathic inflammatory myopathy

Muscle and Nerve, 2015
In 10-20% of patients with subacute-onset idiopathic inflammatory myopathy (IIM), muscle biopsy is normal or shows nonspecific findings. MRI can be used as a triage test before muscle biopsy and as an add-on test if the biopsy is nondiagnostic. MRI scans
Mario Maas, Jessica E Hoogendijk, Marianne De Visser   +2 more
exaly   +2 more sources

Treatment of idiopathic inflammatory myopathies

Current Opinion in Neurology, 2003
This article reviews the results of recent therapeutic trials in dermatomyositis, polymyositis, and inclusion body myositis and suggests an approach to treating patients with inflammatory myopathy.We reviewed 10 double-blind, placebo-controlled therapeutic trials in patients with inflammatory myopathy.
Anthony A, Amato, Robert C, Griggs
openaire   +2 more sources

Chemokines in idiopathic inflammatory myopathies

Frontiers in Bioscience, 2008
The idiopathic inflammatory myopathies (IIM) represent a heterogeneous group of acquired muscle diseases. The three best-studied subgroups: dermatomyositis (DM), polymyositis (PM), and sporadic inclusion body myositis (IBM), differ considerably both clinically and pathophysiologically.
Boel, De Paepe, Kim K, Creus, Jan L, De Bleecker   +2 more
openaire   +2 more sources

Biologics for idiopathic inflammatory myopathies

Current Opinion in Rheumatology, 2017
Purpose of review As treatment of refractory cases of idiopathic inflammatory myopathies (IIMs) has been challenging, there is growing interest in assessing novel biologics that target various pathways implicated in the pathogenesis of IIM.
Siamak, Moghadam-Kia, Rohit, Aggarwal, Chester V, Oddis   +2 more
openaire   +2 more sources

Idiopathic Inflammatory Myopathies

Continuum
This article describes the various idiopathic inflammatory myopathies, including their clinical presentation, pathogenesis, diagnosis, and treatments. While many disorders fall under this umbrella, this article focuses on dermatomyositis, antisynthetase syndrome, immune-mediated necrotizing myopathy, polymyositis, and overlap syndrome.The diagnosis of ...
Mohammad Kian, Salajegheh, Anthony A, Amato   +1 more
openaire   +2 more sources

Idiopathic inflammatory myopathies—a review

Clinical Rheumatology, 2015
The idiopathic inflammatory myopathies (IIM) constitute a subset of autoimmune conditions primarily affecting muscle, along with many extra-muscular manifestations. Proximal muscle weakness is the dominant symptom in the IIM. In addition, many patients will have cutaneous manifestations, pulmonary manifestations, and arthritis.
Jonathan, Jones, Robert, Wortmann
openaire   +2 more sources

Arthritis in Idiopathic Inflammatory Myopathies

Current Rheumatology Reports, 2019
Arthritis is a well-recognized symptom of idiopathic inflammatory myopathies (IIM). We provide a summary of available data regarding the epidemiology, clinical characteristics, and autoantibody associations of joint involvement in various forms of IIM.Arthritis is reported in 18-55% of patients with IIM.
Martin, Klein, Heřman, Mann, Jiří, Vencovský   +2 more
openaire   +2 more sources

Idiopathic inflammatory myopathies

Journal of Neuroimmunology, 2011
The idiopathic inflammatory myopathies (IIM) encompass a heterogeneous group of rare disorders that present with acute, subacute, or chronic muscle weakness. Besides overlapping clinical manifestations, polymyositis, dermatomyositis and autoimmune necrotizing myopathy may be associated with cancer or collagen vascular disease, and respond generally ...
openaire   +2 more sources

Idiopathic inflammatory myopathies – myositis

Best Practice & Research Clinical Rheumatology, 2002
The inflammatory myopathies - myositis - encompass a heterogeneous group of chronic muscle disorders of unknown origin and with varying prognoses. New clinical phenotypes of myositis have been identified since the most widely used classification criteria were proposed in 1975.
Christina, Dorph, Ingrid E, Lundberg
openaire   +2 more sources